Management of Prostate Cancer: A Multidisciplinary Approach
Editat de Michel Bolla, Hendrik van Poppelen Limba Engleză Hardback – 13 mai 2012
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 769.14 lei 38-44 zile | |
| Springer – 13 mai 2012 | 1005.08 lei 22-36 zile | |
| Springer International Publishing – 19 ian 2017 | 769.14 lei 38-44 zile |
Preț: 1005.08 lei
Preț vechi: 1057.98 lei
-5% Nou
Puncte Express: 1508
Preț estimativ în valută:
192.35€ • 203.42$ • 160.45£
192.35€ • 203.42$ • 160.45£
Carte disponibilă
Livrare economică 09-23 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642275968
ISBN-10: 3642275966
Pagini: 360
Ilustrații: 15 schwarz-weiße und 44 farbige Abbildungen
Dimensiuni: 178 x 254 x 23 mm
Greutate: 0.91 kg
Ediția:2012
Editura: Springer
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642275966
Pagini: 360
Ilustrații: 15 schwarz-weiße und 44 farbige Abbildungen
Dimensiuni: 178 x 254 x 23 mm
Greutate: 0.91 kg
Ediția:2012
Editura: Springer
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
V-ar putea interesa
-
-5%Preț: 1008.41 lei1061.49 lei -
Molecular Basis of HematopoiesisAmittha Wickrema-5%Preț: 692.73 lei729.18 lei -
Dendritic Cells in CancerMichael R Shurin-5%Preț: 1065.97 lei1122.07 lei -
Drug Resistance in Cancer CellsSusan E. Bates-5%Preț: 1064.23 lei1120.23 lei -
Stem Cells and CancerSadhan Majumder-5%Preț: 1001.42 lei1054.13 lei -
Treatment of Multiple Myeloma and Related DisordersS. Vincent Rajkumar-5%Preț: 682.90 lei718.84 lei -
Targeted Cancer Immune TherapyJoseph Lustgarten-5%Preț: 1321.73 lei1391.29 lei -
Soft Tissue CancersSota Hasegawa-27%Preț: 840.21 lei1152.33 lei -
Cancer and Stem CellsThomas Dittmar-27%Preț: 741.05 lei1015.84 lei -
Cancer Prevention Research TrendsLouis Braun-27%Preț: 834.89 lei1149.08 lei -
Research Progress in Tumor MarkersEmily Richter-27%Preț: 1110.14 lei1523.89 lei -
-31%Preț: 214.69 lei309.31 lei -
Women and AddictionsLucas H. Andre-27%Preț: 834.46 lei1148.81 lei -
Magnetic Resonance Spectroscopy of Breast TumorsGary M. Tse-27%Preț: 644.02 lei884.86 lei -
-27%Preț: 295.43 lei406.20 lei -
Gut Stem CellsShigeki Bamba-27%Preț: 297.54 lei407.48 lei -
-5%Preț: 531.42 lei559.39 lei -
Polyhedral Boron Hybrides in UseIgor B. Sivaev-27%Preț: 247.37 lei338.88 lei -
Anticancer DrugsPeter Spencer-27%Preț: 959.65 lei1318.08 lei -
-5%Preț: 688.66 lei724.91 lei -
Hepatobiliary and Pancreatic Carcinogenesis in the HamsterYoshitsugu Tajima-5%Preț: 1056.85 lei1112.46 lei
Public țintă
Professional/practitionerCuprins
Epidemiology of prostate cancer in Europe.-Chemoprevention.-Individual and mass screening.-Biology.-Diagnosis, clinical work up, TNM classification.-Markers.-Active surveillance.-Open Radical Prostatectomy.-The robotic laparoscopic radical prostatectomy.-Brachytherapy (Low dose and High dose).-3D-CRT +/- IMRT.-Combination External irradiation- androgen deprivation.-Post-operative irradiation: immediate or early delayed?.-High Intensity Focused Ultrasound.-Cryotherapy.-Follow-up after radical treatment and relapse.-First line hormonal manipulations.-Resistance to chemical castration: Second line hormonal treatment.-Targeted therapies and vaccination.-How to interprete results?.-Prostate EAU guidelines.-Better Patients perspective.-Conclusion.
Recenzii
From the reviews:
“Editors Bolla and Van Poppel, with the contributions of renowned experts, focused on the multidisciplinary approach of managing prostate cancer, and provided the reader with an exhaustive survey. … This textbook provides the reader with an excellent overview of prostate cancer and will be useful for all urologists and oncologists involved in prostate cancer treatment.” (European Urology Today, Vol. 25 (1), January-February, 2013)
“Editors Bolla and Van Poppel, with the contributions of renowned experts, focused on the multidisciplinary approach of managing prostate cancer, and provided the reader with an exhaustive survey. … This textbook provides the reader with an excellent overview of prostate cancer and will be useful for all urologists and oncologists involved in prostate cancer treatment.” (European Urology Today, Vol. 25 (1), January-February, 2013)
Notă biografică
Michel Bolla M.D. is Professor for Radiation Oncology and Oncology. He received his medical degree at the Joseph Fourier University of Grenoble and had his radiation therapy training at the University Hospital of Grenoble and the Comprehensive Cancer Centre Georges François Leclerc in Dijon. He was appointed Professor in 1986 and was particularly involved in the structuring of Oncology at the Grenoble University Hospital: Head of the Radiation Oncology Department (1997-2009), President of the Federation of Oncology (2000-7), President of the Arc Alpin Oncology Network (2002 -2009). Professor Bolla was nominated as President of the French Society of Radiation Oncology (2006-7): he was particularly involved in the definition of radiotherapy quality criteria (Plan Cancer I) and served as project-manager of the French Radiation Therapy Observatory, under the French National cancer Institute and the French Society of Radiation Oncology umbrella. After serving as Secretary of the Radiation Oncology Group of the European Organization on Research and Treatment of Cancer (EORTC) since 1991, Professor Bolla was elected chairman of the Radiation Oncology Group (1997-2000) then member of the EORTC Board (2000-2006). The focus of his clinical research for many years is prostate cancer: indications of adjuvant radiotherapy after radical prostatectomy, combination of androgen deprivation with external irradiation for locally advanced prostate cancer, which earned him several publications on the New England Journal of Medecine and the Lancet. In 2009 the steering Committee of the 2ND European Multidisciplinary Meeting on Urological Cancers (EAU,ESMO, ESTRO) honoured him as recepient of an award for Excellence in Radiation Oncology.As regard screening, he was one of the promoters of breast, cervix and colon and rectal cancers mass screening for women (50-74 years) in Isère (1990) and he is now trying to implement prostate cancer screening in men.
Professor Hein Van Poppel M.D., PhD., is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit Leuven, the largest urological training institute in Belgium.He graduated in General Surgery in 1980, in Urology in 1983 and joined the Academic Unit at the KU Leuven after 2 years of postgraduate training in London, Barcelona, Copenhagen, Mainz and Rotterdam. In 1988, he obtained a PhD in Medical Sciences. He became a Fellow of the European Board of Urology in 1992 and a full Professor of Urology in 1993.He is a board member of the European Association of Urology (EAU), and of the International Consultation on Urological Disease (ICUD). He is study coordinator and treasurer of the EORTC GU Group. He is Chairman of the Educational Office of the EAU and director of the European School of Urology (ESU). He is also member of the American Association of Genito Urinary surgeons (AAGUS). He is president of the Belgian Society of Urology (BVU), Chairman of the Scientific Committee of Europa Uomo and Faculty Member of the European Society of Medical Oncology (ESMO). The clinical focus of his work is on genitourinary cancer management and on primary and salvage surgery for kidney, bladder, prostate and testicular malignancies.He is member of numerous scientific organisations in Europe and worldwide and reviewer for the most prominent urological peer review journals.He has published more than 200 papers as first author on uro-oncological surgery and has co-authored more than 250 other papers.
Professor Hein Van Poppel M.D., PhD., is the Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit Leuven, the largest urological training institute in Belgium.He graduated in General Surgery in 1980, in Urology in 1983 and joined the Academic Unit at the KU Leuven after 2 years of postgraduate training in London, Barcelona, Copenhagen, Mainz and Rotterdam. In 1988, he obtained a PhD in Medical Sciences. He became a Fellow of the European Board of Urology in 1992 and a full Professor of Urology in 1993.He is a board member of the European Association of Urology (EAU), and of the International Consultation on Urological Disease (ICUD). He is study coordinator and treasurer of the EORTC GU Group. He is Chairman of the Educational Office of the EAU and director of the European School of Urology (ESU). He is also member of the American Association of Genito Urinary surgeons (AAGUS). He is president of the Belgian Society of Urology (BVU), Chairman of the Scientific Committee of Europa Uomo and Faculty Member of the European Society of Medical Oncology (ESMO). The clinical focus of his work is on genitourinary cancer management and on primary and salvage surgery for kidney, bladder, prostate and testicular malignancies.He is member of numerous scientific organisations in Europe and worldwide and reviewer for the most prominent urological peer review journals.He has published more than 200 papers as first author on uro-oncological surgery and has co-authored more than 250 other papers.
Textul de pe ultima copertă
This book provides an exhaustive review of the current state of the art in the management of prostate cancer, from screening to treatment. A particular feature is the emphasis placed on the value of a multidisciplinary approach. The opening chapters address basic aspects including epidemiology, biology, and chemoprevention. The role of individual and mass screening is carefully appraised, and diagnosis, clinical work-up, and the role of active surveillance are discussed in detail. Subsequent chapters are devoted to each of the therapies that may be employed, including open and robotic laparoscopic radical prostatectomy, the various forms of radiation therapy, high-intensity focused ultrasound, cryotherapy, hormonal therapy, and targeted therapies and vaccination. Up-to-date data from clinical trials are included. In addition, the EAU guidelines are presented and advice is given on the interpretation of results. The authors are all experts in their field, and the editors are members of the EORTC who have coordinated phase III EORTC trials and have worldwide reputations.
Caracteristici
Exhaustive review of the management of prostate cancer, covering screening, diagnosis, and treatment
Includes up-to-date data from clinical trials
Multidisciplinary approach
Edited by two experts with worldwide reputations who have coordinated phase III EORTC trials
Includes up-to-date data from clinical trials
Multidisciplinary approach
Edited by two experts with worldwide reputations who have coordinated phase III EORTC trials
Descriere
This exhaustive review of prostate cancer management covers epidemiology, biology, chemoprevention, screening and diagnosis, therapies including surgery, radiation, high-intensity ultrasound, cryotherapy, and more. Includes up-to-date clinical trial data.